March 6, 2023 — More than 80% of U.S. adults with type 2 diabetes meet the criteria to use new treatment drugs, such as semaglutide, which is marketed as Ozempic, according to a new study published in the Annals of Internal Medicine. However, only about 1 in 10 of those who meet the criteria used the …
Continue reading “80% With Diabetes Eligible for New Drugs, but Cost Is a Barrier”